Jingxuan Bao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jingxuan Bao has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Li Shen
University of Pennsylvania
14 shared publications - Christos Davatzikos
Artificial Intelligence in Biomedical Imaging Laboratory (AIBIL), Center for AI and Data Science for Integrated Diagnostics (AI2D), Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
5 shared publications - Duy Duong-Tran
University of Pennsylvania
5 shared publications - Junhao Wen
Laboratory of AI and Biomedical Science (LABS), Columbia University, New York, USA
5 shared publications - Andrew J. Saykin
Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
4 shared publications - Guray Erus
Artificial Intelligence in Biomedical Imaging Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
4 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by IOP Publishing in Journal of Neural Engineering
Disentangling homogeneous and heterogeneous representation of human functional connectome via graph learning
Objective. Functional connectivity analysis of fMRI data provides critical insight into large-scale brain organization; however, conventional approaches often ignore the specific information mixed with population-level structure and individual- or condition-specific variability. We aimed to develop an interpretable framework that separates these shared and heterogeneous components of the human functional connectome. Approach. We developed Joint Individual Graph Learning (JIGL), a multi-view graph learning framework that jointly estimates a low-rank common graph and sparse view-specific graphs across subjects or experimental conditions. We evaluated JIGL using resting-state and task-based fMRI data from 422 individuals across eight conditions and compared it with Pearson correlation, SIMLR (CIMLR), and Simplex. Performance was assessed using alignment with established resting-state network organization, associations with age and cognitive phenotypes, task identifiability, and low-dimensional representations of task-specific connectivity. Main results. The common graph learned by JIGL captured a biologically meaningful functional backbone and showed stronger alignment with established resting-state network organization than the comparison methods. JIGL-derived individual graphs preserved biologically relevant inter-individual variability, yielding stronger associations with age and cognitive phenotypes. The task-specific graphs also showed improved identifiability, as quantified by the intraclass correlation coefficient. Furthermore, low-dimensional embeddings of the connectivity matrices revealed structured, network-dependent task signatures that were consistently distinct from both the common graph and the resting-state condition. Significance. JIGL provides a principled framework for disentangling shared functional architecture from individual- and condition-specific connectivity patterns. This decomposition improves sensitivity to biologically meaningful variability and supports more interpretable analyses of functional brain organization across individuals and cognitive states.
- 6 November 2026
- Published by IOP Publishing in Journal of Neural Engineering
Open AccessDisentangling homogeneous and heterogeneous representation of human functional connectome via graph learning
Objective. Functional connectivity analysis of fMRI data provides critical insight into large-scale brain organization; however, conventional approaches often ignore the specific information mixed with population-level structure and individual- or condition-specific variability. We aimed to develop an interpretable framework that separates these shared and heterogeneous components of the human functional connectome. Approach. We developed Joint Individual Graph Learning (JIGL), a multi-view graph learning framework that jointly estimates a low-rank common graph and sparse view-specific graphs across subjects or experimental conditions. We evaluated JIGL using resting-state and task-based fMRI data from 422 individuals across eight conditions and compared it with Pearson correlation, SIMLR (CIMLR), and Simplex. Performance was assessed using alignment with established resting-state network organization, associations with age and cognitive phenotypes, task identifiability, and low-dimensional representations of task-specific connectivity. Main results. The common graph learned by JIGL captured a biologically meaningful functional backbone and showed stronger alignment with established resting-state network organization than the comparison methods. JIGL-derived individual graphs preserved biologically relevant inter-individual variability, yielding stronger associations with age and cognitive phenotypes. The task-specific graphs also showed improved identifiability, as quantified by the intraclass correlation coefficient. Furthermore, low-dimensional embeddings of the connectivity matrices revealed structured, network-dependent task signatures that were consistently distinct from both the common graph and the resting-state condition. Significance. JIGL provides a principled framework for disentangling shared functional architecture from individual- and condition-specific connectivity patterns. This decomposition improves sensitivity to biologically meaningful variability and supports more interpretable analyses of functional brain organization across individuals and cognitive states.
- Open Access
- 12 October 2025
- Published by Association for Computing Machinery (ACM)
- Vol. 2025, 1-10
Fair CCA for Fair Representation Learning: An ADNI Study
Canonical correlation analysis (CCA) is a technique for finding correlations between different data modalities and learning low-dimensional representations. As fairness becomes crucial in machine learning, fair CCA has gained attention. However, previous approaches often overlook the impact on downstream classification tasks, limiting applicability. We propose a novel fair CCA method for fair representation learning, ensuring the projected features are independent of sensitive attributes, thus enhancing fairness without compromising accuracy. We validate our method on synthetic data and real-world data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), demonstrating its ability to maintain high correlation analysis performance while improving fairness in classification tasks. Our work enables fair machine learning in neuroimaging studies where unbiased analysis is essential. Code is available in https://github.com/ZhanliangAaronWang/FR-CCA-ADNI.
- 12 October 2025
- Published by Association for Computing Machinery (ACM)
- Vol. 2025, 1-10
Open AccessFair CCA for Fair Representation Learning: An ADNI Study
Canonical correlation analysis (CCA) is a technique for finding correlations between different data modalities and learning low-dimensional representations. As fairness becomes crucial in machine learning, fair CCA has gained attention. However, previous approaches often overlook the impact on downstream classification tasks, limiting applicability. We propose a novel fair CCA method for fair representation learning, ensuring the projected features are independent of sensitive attributes, thus enhancing fairness without compromising accuracy. We validate our method on synthetic data and real-world data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), demonstrating its ability to maintain high correlation analysis performance while improving fairness in classification tasks. Our work enables fair machine learning in neuroimaging studies where unbiased analysis is essential. Code is available in https://github.com/ZhanliangAaronWang/FR-CCA-ADNI.
- Open Access
- 14 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
A genetically informed brain atlas for enhancing brain imaging genomics
Brain imaging genomics has manifested considerable potential in illuminating the genetic determinants of human brain structure and function. This has propelled us to develop the GIANT (Genetically Informed brAiN aTlas) that accounts for genetic and neuroanatomical variations simultaneously. Integrating voxel-wise heritability and spatial proximity, GIANT clusters brain voxels into genetically informed regions, while retaining fundamental anatomical knowledge. Compared to conventional (non-genetics) brain atlases, GIANT exhibits smaller intra-region variations and larger inter-region variations in terms of voxel-wise heritability. As a result, GIANT yields increased regional SNP heritability, enhanced polygenicity, and its polygenic risk score explains more brain volumetric variation than traditional neuroanatomical brain atlases. We provide extensive validation to GIANT and demonstrate its neuroanatomical validity, confirming its generalizability across populations with diverse genetic ancestries and various brain conditions. Furthermore, we present a comprehensive genetic architecture of the GIANT regions, covering their functional annotation at the molecular levels, their associations with other complex traits/diseases, and the genetic and phenotypic correlations among GIANT-defined imaging endophenotypes. In summary, GIANT constitutes a brain atlas that captures the complexity of genetic and neuroanatomical heterogeneity, thereby enhancing the discovery power and applicability of imaging genomics investigations in biomedical science.
- 14 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessA genetically informed brain atlas for enhancing brain imaging genomics
Brain imaging genomics has manifested considerable potential in illuminating the genetic determinants of human brain structure and function. This has propelled us to develop the GIANT (Genetically Informed brAiN aTlas) that accounts for genetic and neuroanatomical variations simultaneously. Integrating voxel-wise heritability and spatial proximity, GIANT clusters brain voxels into genetically informed regions, while retaining fundamental anatomical knowledge. Compared to conventional (non-genetics) brain atlases, GIANT exhibits smaller intra-region variations and larger inter-region variations in terms of voxel-wise heritability. As a result, GIANT yields increased regional SNP heritability, enhanced polygenicity, and its polygenic risk score explains more brain volumetric variation than traditional neuroanatomical brain atlases. We provide extensive validation to GIANT and demonstrate its neuroanatomical validity, confirming its generalizability across populations with diverse genetic ancestries and various brain conditions. Furthermore, we present a comprehensive genetic architecture of the GIANT regions, covering their functional annotation at the molecular levels, their associations with other complex traits/diseases, and the genetic and phenotypic correlations among GIANT-defined imaging endophenotypes. In summary, GIANT constitutes a brain atlas that captures the complexity of genetic and neuroanatomical heterogeneity, thereby enhancing the discovery power and applicability of imaging genomics investigations in biomedical science.
- Open Access
- 12 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Automated cytometric gating with human-level performance using bivariate segmentation
Recent advances in cytometry have enabled high-throughput data collection with multiple single-cell protein expression measurements. The significant biological and technical variance in cytometry has posed a formidable challenge during the gating process, especially for the initial pre-gates which deal with unpredictable events, such as debris and technical artifacts. To mitigate the labor-intensive manual gating process, we propose UNITO, a framework to rigorously identify the hierarchical cytometric subpopulations. UNITO transforms a cell-level classification task into an image-based segmentation problem. The framework is validated on three independent cohorts (two mass cytometry and one flow cytometry datasets). We compare its results with previous automated methods using the consensus of at least four experienced immunologists. UNITO outperforms existing methods and deviates from human consensus by no more than any individual does. UNITO can reproduce a similar contour compared to manual gating for post-hoc inspection, and it also allows parallelization of samples for faster processing.
- 12 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessAutomated cytometric gating with human-level performance using bivariate segmentation
Recent advances in cytometry have enabled high-throughput data collection with multiple single-cell protein expression measurements. The significant biological and technical variance in cytometry has posed a formidable challenge during the gating process, especially for the initial pre-gates which deal with unpredictable events, such as debris and technical artifacts. To mitigate the labor-intensive manual gating process, we propose UNITO, a framework to rigorously identify the hierarchical cytometric subpopulations. UNITO transforms a cell-level classification task into an image-based segmentation problem. The framework is validated on three independent cohorts (two mass cytometry and one flow cytometry datasets). We compare its results with previous automated methods using the consensus of at least four experienced immunologists. UNITO outperforms existing methods and deviates from human consensus by no more than any individual does. UNITO can reproduce a similar contour compared to manual gating for post-hoc inspection, and it also allows parallelization of samples for faster processing.
- Open Access
Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease
Alzheimer’s disease is a neurodegenerative disease that continues to have a rising number of cases. While extensive research has been conducted on Alzheimer’s disease in the last few decades, only a few drugs have been approved by the FDA for its treatment, and even fewer aim to be curative rather than manage symptoms. There remains an urgent need to understand disease pathogenesis, as well as identify new targets for further drug discovery. Alzheimer’s disease (AD) is known to stem from the build-up of amyloid beta (Aβ) plaques, as well as tangles of tau proteins. Furthermore, inflammation in the brain is known to arise from the degeneration of tissue and the build-up of insoluble material. Therefore, there is a potential link between the pathology of AD and inflammation in the brain, especially as the disease progresses to later stages, where neuronal death and degeneration levels are higher. Proteins that are relevant to both brain inflammation and AD, thus, make ideal potential targets for therapeutics; however, the proteins need to be evaluated to determine which targets would be ideal for potential drug therapeutic treatments, or ‘druggable’ targets. Druggability analysis was conducted using two structure-based methods (i.e., drug-like density analysis and SiteMap), as well as a sequence-based approach, SPIDER. The most druggable targets were then evaluated using single-nucleus sequencing data for their clinical relevance to inflammation in AD. For each of the top five targets, small molecule docking was used to evaluate which FDA approved drugs were able to bind with the chosen proteins. The top targets included DRD2 (inhibits adenylyl cyclase activity), C9 (binds with C5B8 to form the membrane attack complex), C4b (binds with C2a to form C3 convertase), C5AR1 (a GPCR that binds C5a), and GABA-A-R (the GPCR involved in inhibiting neurotransmission). Each target had multiple potential inhibitors from the FDA-approved drug list with decent binding infinities. Among these inhibitors, two drugs were found to be top inhibitors for more than one protein target. They were C15H14N2O2 and v316 (paracetamol), originally used to treat pain/inflammation for cataracts and relieve headaches/fever, respectively. These results provide the groundwork for further experimental investigations or clinical trials.
Open AccessRepurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease
Alzheimer’s disease is a neurodegenerative disease that continues to have a rising number of cases. While extensive research has been conducted on Alzheimer’s disease in the last few decades, only a few drugs have been approved by the FDA for its treatment, and even fewer aim to be curative rather than manage symptoms. There remains an urgent need to understand disease pathogenesis, as well as identify new targets for further drug discovery. Alzheimer’s disease (AD) is known to stem from the build-up of amyloid beta (Aβ) plaques, as well as tangles of tau proteins. Furthermore, inflammation in the brain is known to arise from the degeneration of tissue and the build-up of insoluble material. Therefore, there is a potential link between the pathology of AD and inflammation in the brain, especially as the disease progresses to later stages, where neuronal death and degeneration levels are higher. Proteins that are relevant to both brain inflammation and AD, thus, make ideal potential targets for therapeutics; however, the proteins need to be evaluated to determine which targets would be ideal for potential drug therapeutic treatments, or ‘druggable’ targets. Druggability analysis was conducted using two structure-based methods (i.e., drug-like density analysis and SiteMap), as well as a sequence-based approach, SPIDER. The most druggable targets were then evaluated using single-nucleus sequencing data for their clinical relevance to inflammation in AD. For each of the top five targets, small molecule docking was used to evaluate which FDA approved drugs were able to bind with the chosen proteins. The top targets included DRD2 (inhibits adenylyl cyclase activity), C9 (binds with C5B8 to form the membrane attack complex), C4b (binds with C2a to form C3 convertase), C5AR1 (a GPCR that binds C5a), and GABA-A-R (the GPCR involved in inhibiting neurotransmission). Each target had multiple potential inhibitors from the FDA-approved drug list with decent binding infinities. Among these inhibitors, two drugs were found to be top inhibitors for more than one protein target. They were C15H14N2O2 and v316 (paracetamol), originally used to treat pain/inflammation for cataracts and relieve headaches/fever, respectively. These results provide the groundwork for further experimental investigations or clinical trials.
- Open Access
- 5 October 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-14
Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum
Alzheimer’s disease (AD) is associated with heterogeneous atrophy patterns. We employed a semi-supervised representation learning technique known as Surreal-GAN, through which we identified two latent dimensional representations of brain atrophy in symptomatic mild cognitive impairment (MCI) and AD patients: the “diffuse-AD” (R1) dimension shows widespread brain atrophy, and the “MTL-AD” (R2) dimension displays focal medial temporal lobe (MTL) atrophy. Critically, only R2 was associated with widely known sporadic AD genetic risk factors (e.g., APOE ε4) in MCI and AD patients at baseline. We then independently detected the presence of the two dimensions in the early stages by deploying the trained model in the general population and two cognitively unimpaired cohorts of asymptomatic participants. In the general population, genome-wide association studies found 77 genes unrelated to APOE differentially associated with R1 and R2. Functional analyses revealed that these genes were overrepresented in differentially expressed gene sets in organs beyond the brain (R1 and R2), including the heart (R1) and the pituitary gland, muscle, and kidney (R2). These genes were enriched in biological pathways implicated in dendritic cells (R2), macrophage functions (R1), and cancer (R1 and R2). Several of them were “druggable genes” for cancer (R1), inflammation (R1), cardiovascular diseases (R1), and diseases of the nervous system (R2). The longitudinal progression showed that APOE ε4, amyloid, and tau were associated with R2 at early asymptomatic stages, but this longitudinal association occurs only at late symptomatic stages in R1. Our findings deepen our understanding of the multifaceted pathogenesis of AD beyond the brain. In early asymptomatic stages, the two dimensions are associated with diverse pathological mechanisms, including cardiovascular diseases, inflammation, and hormonal dysfunction—driven by genes different from APOE—which may collectively contribute to the early pathogenesis of AD. All results are publicly available at https://labs-laboratory.com/medicine/.
- 5 October 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-14
Open AccessGenetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum
Alzheimer’s disease (AD) is associated with heterogeneous atrophy patterns. We employed a semi-supervised representation learning technique known as Surreal-GAN, through which we identified two latent dimensional representations of brain atrophy in symptomatic mild cognitive impairment (MCI) and AD patients: the “diffuse-AD” (R1) dimension shows widespread brain atrophy, and the “MTL-AD” (R2) dimension displays focal medial temporal lobe (MTL) atrophy. Critically, only R2 was associated with widely known sporadic AD genetic risk factors (e.g., APOE ε4) in MCI and AD patients at baseline. We then independently detected the presence of the two dimensions in the early stages by deploying the trained model in the general population and two cognitively unimpaired cohorts of asymptomatic participants. In the general population, genome-wide association studies found 77 genes unrelated to APOE differentially associated with R1 and R2. Functional analyses revealed that these genes were overrepresented in differentially expressed gene sets in organs beyond the brain (R1 and R2), including the heart (R1) and the pituitary gland, muscle, and kidney (R2). These genes were enriched in biological pathways implicated in dendritic cells (R2), macrophage functions (R1), and cancer (R1 and R2). Several of them were “druggable genes” for cancer (R1), inflammation (R1), cardiovascular diseases (R1), and diseases of the nervous system (R2). The longitudinal progression showed that APOE ε4, amyloid, and tau were associated with R2 at early asymptomatic stages, but this longitudinal association occurs only at late symptomatic stages in R1. Our findings deepen our understanding of the multifaceted pathogenesis of AD beyond the brain. In early asymptomatic stages, the two dimensions are associated with diverse pathological mechanisms, including cardiovascular diseases, inflammation, and hormonal dysfunction—driven by genes different from APOE—which may collectively contribute to the early pathogenesis of AD. All results are publicly available at https://labs-laboratory.com/medicine/.
- Open Access
- 24 September 2024
- Published by MDPI AG in Mathematics
- Vol. 12 (19)
A Principled Framework to Assess the Information-Theoretic Fitness of Brain Functional Sub-Circuits
In systems and network neuroscience, many common practices in brain connectomic analysis are often not properly scrutinized. One such practice is mapping a predetermined set of sub-circuits, like functional networks (FNs), onto subjects’ functional connectomes (FCs) without adequately assessing the information-theoretic appropriateness of the partition. Another practice that goes unchallenged is thresholding weighted FCs to remove spurious connections without justifying the chosen threshold. This paper leverages recent theoretical advances in Stochastic Block Models (SBMs) to formally define and quantify the information-theoretic fitness (e.g., prominence) of a predetermined set of FNs when mapped to individual FCs under different fMRI task conditions. Our framework allows for evaluating any combination of FC granularity, FN partition, and thresholding strategy, thereby optimizing these choices to preserve the important topological features of the human brain connectomes. By applying to the Human Connectome Project with Schaefer parcellations at multiple levels of granularity, the framework showed that the common thresholding value of 0.25 was indeed information-theoretically valid for group-average FCs, despite its previous lack of justification. Our results pave the way for the proper use of FNs and thresholding methods, and provide insights for future research in individualized parcellations.
- 24 September 2024
- Published by MDPI AG in Mathematics
- Vol. 12 (19)
Open AccessA Principled Framework to Assess the Information-Theoretic Fitness of Brain Functional Sub-Circuits
In systems and network neuroscience, many common practices in brain connectomic analysis are often not properly scrutinized. One such practice is mapping a predetermined set of sub-circuits, like functional networks (FNs), onto subjects’ functional connectomes (FCs) without adequately assessing the information-theoretic appropriateness of the partition. Another practice that goes unchallenged is thresholding weighted FCs to remove spurious connections without justifying the chosen threshold. This paper leverages recent theoretical advances in Stochastic Block Models (SBMs) to formally define and quantify the information-theoretic fitness (e.g., prominence) of a predetermined set of FNs when mapped to individual FCs under different fMRI task conditions. Our framework allows for evaluating any combination of FC granularity, FN partition, and thresholding strategy, thereby optimizing these choices to preserve the important topological features of the human brain connectomes. By applying to the Human Connectome Project with Schaefer parcellations at multiple levels of granularity, the framework showed that the common thresholding value of 0.25 was indeed information-theoretically valid for group-average FCs, despite its previous lack of justification. Our results pave the way for the proper use of FNs and thresholding methods, and provide insights for future research in individualized parcellations.
- Open Access
- 23 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
The genetic architecture of multimodal human brain age
The complex biological mechanisms underlying human brain aging remain incompletely understood. This study investigated the genetic architecture of three brain age gaps (BAG) derived from gray matter volume (GM-BAG), white matter microstructure (WM-BAG), and functional connectivity (FC-BAG). We identified sixteen genomic loci that reached genome-wide significance (P-value < 5×10−8). A gene-drug-disease network highlighted genes linked to GM-BAG for treating neurodegenerative and neuropsychiatric disorders and WM-BAG genes for cancer therapy. GM-BAG displayed the most pronounced heritability enrichment in genetic variants within conserved regions. Oligodendrocytes and astrocytes, but not neurons, exhibited notable heritability enrichment in WM and FC-BAG, respectively. Mendelian randomization identified potential causal effects of several chronic diseases on brain aging, such as type 2 diabetes on GM-BAG and AD on WM-BAG. Our results provide insights into the genetics of human brain aging, with clinical implications for potential lifestyle and therapeutic interventions. All results are publicly available at https://labs.loni.usc.edu/medicine.
- 23 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessThe genetic architecture of multimodal human brain age
The complex biological mechanisms underlying human brain aging remain incompletely understood. This study investigated the genetic architecture of three brain age gaps (BAG) derived from gray matter volume (GM-BAG), white matter microstructure (WM-BAG), and functional connectivity (FC-BAG). We identified sixteen genomic loci that reached genome-wide significance (P-value < 5×10−8). A gene-drug-disease network highlighted genes linked to GM-BAG for treating neurodegenerative and neuropsychiatric disorders and WM-BAG genes for cancer therapy. GM-BAG displayed the most pronounced heritability enrichment in genetic variants within conserved regions. Oligodendrocytes and astrocytes, but not neurons, exhibited notable heritability enrichment in WM and FC-BAG, respectively. Mendelian randomization identified potential causal effects of several chronic diseases on brain aging, such as type 2 diabetes on GM-BAG and AD on WM-BAG. Our results provide insights into the genetics of human brain aging, with clinical implications for potential lifestyle and therapeutic interventions. All results are publicly available at https://labs.loni.usc.edu/medicine.
- Open Access
- 31 January 2024
- Published by MDPI AG in Mathematics
- Vol. 12 (3) , 455
Homological Landscape of Human Brain Functional Sub-Circuits
Human whole-brain functional connectivity networks have been shown to exhibit both local/quasilocal (e.g., a set of functional sub-circuits induced by node or edge attributes) and non-local (e.g., higher-order functional coordination patterns) properties. Nonetheless, the non-local properties of topological strata induced by local/quasilocal functional sub-circuits have yet to be addressed. To that end, we proposed a homological formalism that enables the quantification of higher-order characteristics of human brain functional sub-circuits. Our results indicate that each homological order uniquely unravels diverse, complementary properties of human brain functional sub-circuits. Noticeably, the homological distance between rest and motor task was observed at both the whole-brain and sub-circuit consolidated levels, which suggested the self-similarity property of human brain functional connectivity unraveled by a homological kernel. Furthermore, at the whole-brain level, the rest–task differentiation was found to be most prominent between rest and different tasks at different homological orders: (i) Emotion task (), (ii) Motor task (), and (iii) Working memory task (). At the functional sub-circuit level, the rest–task functional dichotomy of the default mode network is found to be mostly prominent at the first and second homological scaffolds. Also at such scale, we found that the limbic network plays a significant role in homological reconfiguration across both the task and subject domains, which paves the way for subsequent investigations on the complex neuro-physiological role of such network. From a wider perspective, our formalism can be applied, beyond brain connectomics, to study the non-localized coordination patterns of localized structures stretching across complex network fibers.- 31 January 2024
- Published by MDPI AG in Mathematics
- Vol. 12 (3) , 455
Open AccessHomological Landscape of Human Brain Functional Sub-Circuits
Human whole-brain functional connectivity networks have been shown to exhibit both local/quasilocal (e.g., a set of functional sub-circuits induced by node or edge attributes) and non-local (e.g., higher-order functional coordination patterns) properties. Nonetheless, the non-local properties of topological strata induced by local/quasilocal functional sub-circuits have yet to be addressed. To that end, we proposed a homological formalism that enables the quantification of higher-order characteristics of human brain functional sub-circuits. Our results indicate that each homological order uniquely unravels diverse, complementary properties of human brain functional sub-circuits. Noticeably, the homological distance between rest and motor task was observed at both the whole-brain and sub-circuit consolidated levels, which suggested the self-similarity property of human brain functional connectivity unraveled by a homological kernel. Furthermore, at the whole-brain level, the rest–task differentiation was found to be most prominent between rest and different tasks at different homological orders: (i) Emotion task (), (ii) Motor task (), and (iii) Working memory task (). At the functional sub-circuit level, the rest–task functional dichotomy of the default mode network is found to be mostly prominent at the first and second homological scaffolds. Also at such scale, we found that the limbic network plays a significant role in homological reconfiguration across both the task and subject domains, which paves the way for subsequent investigations on the complex neuro-physiological role of such network. From a wider perspective, our formalism can be applied, beyond brain connectomics, to study the non-localized coordination patterns of localized structures stretching across complex network fibers. - Open Access
- 8 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Gene-SGAN: discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clustering
Disease heterogeneity has been a critical challenge for precision diagnosis and treatment, especially in neurologic and neuropsychiatric diseases. Many diseases can display multiple distinct brain phenotypes across individuals, potentially reflecting disease subtypes that can be captured using MRI and machine learning methods. However, biological interpretability and treatment relevance are limited if the derived subtypes are not associated with genetic drivers or susceptibility factors. Herein, we describe Gene-SGAN – a multi-view, weakly-supervised deep clustering method – which dissects disease heterogeneity by jointly considering phenotypic and genetic data, thereby conferring genetic correlations to the disease subtypes and associated endophenotypic signatures. We first validate the generalizability, interpretability, and robustness of Gene-SGAN in semi-synthetic experiments. We then demonstrate its application to real multi-site datasets from 28,858 individuals, deriving subtypes of Alzheimer’s disease and brain endophenotypes associated with hypertension, from MRI and single nucleotide polymorphism data. Derived brain phenotypes displayed significant differences in neuroanatomical patterns, genetic determinants, biological and clinical biomarkers, indicating potentially distinct underlying neuropathologic processes, genetic drivers, and susceptibility factors. Overall, Gene-SGAN is broadly applicable to disease subtyping and endophenotype discovery, and is herein tested on disease-related, genetically-associated neuroimaging phenotypes.
- 8 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessGene-SGAN: discovering disease subtypes with imaging and genetic signatures via multi-view weakly-supervised deep clustering
Disease heterogeneity has been a critical challenge for precision diagnosis and treatment, especially in neurologic and neuropsychiatric diseases. Many diseases can display multiple distinct brain phenotypes across individuals, potentially reflecting disease subtypes that can be captured using MRI and machine learning methods. However, biological interpretability and treatment relevance are limited if the derived subtypes are not associated with genetic drivers or susceptibility factors. Herein, we describe Gene-SGAN – a multi-view, weakly-supervised deep clustering method – which dissects disease heterogeneity by jointly considering phenotypic and genetic data, thereby conferring genetic correlations to the disease subtypes and associated endophenotypic signatures. We first validate the generalizability, interpretability, and robustness of Gene-SGAN in semi-synthetic experiments. We then demonstrate its application to real multi-site datasets from 28,858 individuals, deriving subtypes of Alzheimer’s disease and brain endophenotypes associated with hypertension, from MRI and single nucleotide polymorphism data. Derived brain phenotypes displayed significant differences in neuroanatomical patterns, genetic determinants, biological and clinical biomarkers, indicating potentially distinct underlying neuropathologic processes, genetic drivers, and susceptibility factors. Overall, Gene-SGAN is broadly applicable to disease subtyping and endophenotype discovery, and is herein tested on disease-related, genetically-associated neuroimaging phenotypes.